Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tripos Discovery Informatics is a leading provider of cheminformatics and molecular modeling software solutions for the life sciences industry. Originally founded in 1979 and now a part of Certara, the company is best known for developing the SYBYL molecular modeling suite and the Comparative Molecular Field Analysis (CoMFA) technology. Their tools enable researchers to perform complex tasks such as lead optimization, virtual screening, and structure-activity relationship modeling. By integrating computational chemistry with experimental data, Tripos helps pharmaceutical companies accelerate the identification and development of new drug candidates. The company's legacy includes pioneering the commercialization of 3D-QSAR and docking algorithms that remain influential in drug design today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tripos Discovery Informatics.